Does microneedling help hair loss?
Most trials of microneedling for hair loss added it to minoxidil and compared that with minoxidil alone. A 2025 review of 12 such trials, with 631 people, found hair counts rose more with the combination, but rated every trial as raising "some concern" about bias, and the largest trial since, in 245 women, found no added benefit. These trials show what needling may add to minoxidil, not what it does alone: in pattern hair loss, no completed trial has compared it with no treatment or a sham procedure, and the few that compared it with minoxidil were small.
Added to minoxidil
The first trial, run in Mumbai in 2011 and 2012, randomly assigned 100 men aged 20 to 35 to 5% minoxidil twice a day, with or without a weekly 1.5 mm dermaroller session, for 12 weeks. A blinded evaluator counted hairs on photographs of a shaved patch: an average gain of 91.4 per square centimetre with needling against 22.2 without. The men knew which treatment they had, and all six dropouts were in the minoxidil group. A 2018 Indian trial of similar design in 68 men found gains of about 12.5 against 1.9 hairs per square inch, which its authors called "not cosmetically significant". Neither trial reported outside funding. A 2025 review of 12 such trials, with 631 people, pooled hair counts from ten of them: they rose more with the combination, but results varied widely, and the review rated every trial as raising "some concern" about bias.
The largest trial found no added benefit
The largest trial we found, published in 2026, randomly assigned 245 women with mild to moderate pattern hair loss, at a single centre, to 2% minoxidil alone or with microneedling every two or every four weeks, using a 36-needle cartridge set to 0.5 to 0.55 mm, for 24 weeks. Counts of non-vellus hairs rose in all three groups, with no significant difference between them, and the authors concluded that needling "did not provide additional clinical benefit". The trial was open-label. An earlier trial in 120 women in Beijing had found the opposite: with an electric needling device every two weeks on top of 5% minoxidil once a day, density rose by about 30 hairs per square centimetre over 24 weeks, against 10 with minoxidil alone. Its authors say their once-daily minoxidil-alone group may have been an inappropriate comparison. The trial was funded by a Beijing public science foundation.
Microneedling on its own
In pattern hair loss, no completed trial has compared microneedling alone with no treatment or with a sham procedure. One is under way: a split-scalp trial in Taiwan, needling one side of the head and leaving the other untreated, started in June 2026 and is expected to finish at the end of the year. Against minoxidil, the evidence is thin. In a Chinese trial with 20 men per group, density rose over 24 weeks by 23.4 hairs per square centimetre with needling alone and by 18.8 with 5% minoxidil; the abstract reports no test of that difference. A 2023 network analysis of 27 trials, only three with a needling-alone group, ranked needling alone below minoxidil alone, but the difference was not statistically significant. A 2023 Brazilian trial with no untreated group gave 30 men four monthly sessions of needling alone, with a 1.5 mm roller or a tattoo machine, and found no gain in hair density.
Rollers at home, pens in the clinic
Most trials were run in clinics, with a dermaroller or an electric microneedling pen, often called a dermapen. Sessions ran from weekly to monthly, with needles usually 0.5 to 1.5 mm long, sometimes after a numbing cream, and continued until redness or pinpoint bleeding. We found only one trial of a device made for home use. Its 29 participants used it twice a week for six months, alone or with minoxidil, or used minoxidil alone, and hair counts did not differ significantly between the three groups. A 2021 review of microneedling side effects across all uses notes that dermarollers and derma stamps are sold over the counter, so buyers need to know safe technique, and that one of the two infections it found followed home use of a roller on the chest and face.
Side effects and reported harms
In the seven trials that reported side effects, the 2025 review counted 74 adverse events with needling plus minoxidil and 59 with minoxidil alone, generally mild or short-lived; itching was more common with minoxidil alone, while nine cases of swollen lymph nodes and one infection occurred only in needled groups. In the Brazilian trial, pain during sessions averaged 6.75 out of 10 despite a numbing cream, and biopsies four months after the last session showed new collagen in 6 of 19 men and loss of elastic fibres in 4, changes its authors treat as signs of a scarring process. Case reports describe hair shafts breaking after months of weekly needling with a 0.5 mm roller, and an abscess under the scalp that spread inside the skull in a man who had used a roller on himself, without antiseptic precautions, over a head injury that had fractured his skull three months earlier. A 2021 review covering all body sites lists tram-track scars and granulomatous reactions among persistent serious effects.
What guidelines and regulators say
A 2025 Canadian consensus of 11 physicians lists microneedling among the seven of 45 treatments for pattern hair loss that it recommends; its published summary does not say whether alone or with minoxidil. In the US, the FDA placed microneedling devices for aesthetic use in class II in 2018, with special controls that include sterile needles, a stated maximum penetration depth and validated cleaning instructions for reusable parts; the class excludes devices meant to deliver drugs or cosmetics through the skin. FDA guidance from 2020 says a product claimed to treat hair loss would generally be a medical device. In France, answering a parliamentary question in June 2025, the government stated that microneedling that breaks the skin requires a medical intervention and is forbidden to beauticians, and that no public expert assessment currently shows it to be free of health risk.
In the register
- Minoxidil (topical)ApprovedUnknownHigh
Related questions
Sources
- A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study · International Journal of Trichology, 2013 · PMID 23960389
- A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia · Journal of Cutaneous and Aesthetic Surgery, 2018 · PMID 30886475
- Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis · Archives of Dermatological Research, 2025 · PMID 40056230
- Microneedle frequency adjunct to 2% minoxidil in female androgenetic alopecia: A randomized controlled trial · Journal of the American Academy of Dermatology, 2026 · PMID 42190753
- Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial · Frontiers in Medicine, 2022 · PMID 35899211
- Microneedling for Androgenic Alopecia: a Clinical Study · ClinicalTrials.gov, 2026 · NCT07580521
- Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia · Journal of Cosmetic and Laser Therapy, 2020 · PMID 29028377
- Efficacy and Safety of Scalp Microneedling in Male Pattern Hair Loss · Skin Appendage Disorders, 2023 · PMID 36636456
- Relative Effects of Minoxidil 5%, Platelet-Rich Plasma, and Microneedling in Pattern Hair Loss: A Systematic Review and Network Meta-Analysis · Skin Appendage Disorders, 2023 · PMID 38058547
- Usefulness of home-use microneedle devices in the treatment of pattern hair loss · Journal of Cosmetic Dermatology, 2021 · PMID 32516497
- A Systematic Review Examining the Potential Adverse Effects of Microneedling · Journal of Clinical and Aesthetic Dermatology, 2021 · PMID 33584968
- When Microneedling Backfires: A Hidden Risk of Hair Shaft Fragility in AGA Patients · Journal of Cosmetic Dermatology, 2026 · PMID 41555747
- Subpericranial and epidural abscess with skull osteomyelitis as a complication of microneedling for alopecia: A singular case report · Surgical Neurology International, 2026 · PMID 42829587
- Safety Profile for Microneedling: A Systematic Review · Dermatologic Surgery, 2021 · PMID 34448760
- A Canadian Consensus on Androgenetic Alopecia: Approach and Management · Journal of Cutaneous Medicine and Surgery, 2025 · PMID 40986632
- Medical Devices; General and Plastic Surgery Devices; Classification of the Microneedling Device for Aesthetic Use · US Food and Drug Administration (Federal Register), 2018 · 83 FR 26575
- Regulatory Considerations for Microneedling Products: Guidance for Industry and Food and Drug Administration Staff · US Food and Drug Administration, 2020
- Question écrite n° 5887 : Définition juridique des soins esthétiques · Assemblée nationale, 2025
Checked against its sources on 2026-11-02, by us, not by a doctor. A research register, not medical advice: talk to a dermatologist about your own case. See why we're not doctors.